Elanco Animal Health Announces U.S. Food and Drug Administration (FDA) Approval of Credelio(R) (lotilaner) to Treat and Protect Against Ticks and Fleas

New monthly oral tick and flea treatment offers easy dosing, efficacy in as little as four hours, all month long GREENFIELD, Ind., Jan. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Today, Elanco Animal Health, a division of Eli Lilly and Comp... Biopharmaceuticals, FDA Elanco Animal Health, Eli Lilly, Credelio, lotilaner

http://salesandmarketingnetwork.com/news_release_bs.html?ID=2043427

Source: HSMN NewsFeed - January 22, 2018 Category: Pharmaceuticals Source Type: news

More News: Food and Drug Administration (FDA) | Marketing | Pharmaceuticals